CARA - キャラ・セラピュ―ティックス (Cara Therapeutics Inc.) キャラ・セラピュ―ティックス

 CARAのチャート


 CARAの企業情報

symbol CARA
会社名 Cara Therapeutics Inc (キャラ・セラピュ―ティックス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 キャラ・セラピューティックス(Cara Therapeutics Inc.)は、臨床段階のバイオ医薬品会社である。同社は、カッパオピオイド 受容体に焦点を当てて痛みとかゆみを緩和するように設計された化学物質の開発と商品化に注力する。同社は、体の末梢神経系を標的とする一連の候補製品を開発する。同社は、疼痛およびかゆみを含む重大な病状を治療するための治療薬の発見及び開発に関連する活動を行う。同社の候補製品パイプラインは、急性疼痛と尿毒症性掻痒症の向けのI.V. CR845、急性および慢性疼痛向けのOral CR845、神経因性疼痛および炎症性疼痛向けのCR701を含む。I.V. CR845は急性期診療における急性疼痛の治療を目的とする、末梢κオピオイド受容体アゴニストの注射可能なバージョンである。CR845は、標準的な前臨床モデルにおいて、抗掻痒性または抗かゆみ性を展示する。   キャラ・セラピュ―ティックスは、臨床段階の米国のバイオ医薬品会社。痛みを軽減するための化学物質の開発・商品化に焦点を当てる。主要製品候補は、疼痛緩和を提供する「IV CR845」注射薬、外来における急性または慢性疼痛を有する患者の痛みの緩和に「CR845」飲み薬、また末梢限定「CR701」薬がある。   
本社所在地 4 Stamford Plaza 107 Elm Street 9th Floor Stamford CT 06902 USA
代表者氏名 Derek T. Chalmers デレク・T・チャーマーズ
代表者役職名 President Chief Executive Officer Director 社長兼最高経営責任者(CEO)
電話番号 +1 203-406-3700
設立年月日 38169
市場名 NASDAQ National Market System
ipoyear 2014年
従業員数 11人
url www.caratherapeutics.com
nasdaq_url https://www.nasdaq.com/symbol/cara
adr_tso
EBITDA EBITDA(百万ドル) -61.97500
終値(lastsale) 20.2
時価総額(marketcap) 793667372.8
時価総額 時価総額(百万ドル) 784.23770
売上高 売上高(百万ドル) 2.87400
企業価値(EV) 企業価値(EV)(百万ドル) 653.97170
当期純利益 当期純利益(百万ドル) -34.66900
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Cara Therapeutics Inc revenues increased from $911K to $2.9M. Net loss increased 8% to $34M. Revenues reflect License and milestone fees revenue increase from $530K to $2.9M. Higher net loss reflects Research and development - Balancing v increase of 9% to $28.7M (expense) Stock-based Compensation in SGA increase of 94% to $2.4M (expense).

 CARAのテクニカル分析


 CARAのニュース

   Cannabis Stock Gainers And Losers From April 9, 2021  2021/04/09 20:43:43 Benzinga
GAINERS: Primo Nutraceuticals (OTC: BUGVF ) shares closed up 33.33% at $0.20 Inner Spirit Holdings (OTC: INSHF ) shares closed up 9.69% at $0.21 Greenlane Holdings (NASDAQ: GNLN ) shares closed up 8.44% at $6.04 EnWave (OTC: NWVCF ) shares closed up 7.44% at $1.30 RIV Capital (OTC: CNPOF ) shares closed up 6.67% at $1.92 Cara Therapeutics (NASDAQ: CARA ) … Full story available on Benzinga.com
   Cara Therapeutics to Present at the 20th Annual Needham Healthcare Conference  2021/04/07 16:01:00 Benzinga
STAMFORD, Conn., April 07, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (NASDAQ:CARA), a biopharmaceutical company focused on developing and …
   Implied Volatility Surging for Cara Therapeutics (CARA) Stock Options | Investing.com  2021/04/07 13:00:58 Investing.com
Stocks Analysis by Zacks Investment Research covering: Cara Therapeutic. Read Zacks Investment Research's latest article on Investing.com
   Illumina, Cara Therapeutics rise; Greenbrier, Paychex fall  2021/04/06 20:23:14 ABC News
Stocks that traded heavily or had substantial price changes Tuesday: Illumina, Cara Therapeutics rise; Greenbrier, Paychex fall
   Cannabis Stock Gainers And Losers From April 5, 2021  2021/04/05 21:13:27 Benzinga
GAINERS: BioHarvest Sciences (OTC: CNVCF ) shares closed up 12.8% at $0.45 Emerald Health (OTC: EMHTF ) shares closed up 11.84% at $0.24 Cara Therapeutics (NASDAQ: CARA ) shares closed up 9.52% at $23.82 CV Sciences (OTC: CVSI ) shares closed up 6.52% at $0.49 The Flowr (OTC: FLWPF ) shares closed up 4.58% at $0.26 Australis Capital (OTC: AUSAF ) shares closed up 4.22% at $0.32 Zenabis Global (OTC: ZBISF ) shares closed up 3.99% at $0.10 Zelira Therapeutics (OTC: ZLDAF ) shares closed up 3.84% at $0.05 Neptune Wellness … Full story available on Benzinga.com
   Knight, Cara, HBCU bands among NBA All-Star Game performers  2021/02/23 14:53:27 ABC News
Atlanta native Gladys Knight will be among the headline performers at the NBA All-Star Game on March 7, performing “The Star-Spangled Banner” during the pregame festivities
   Cara Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021  2021/02/18 16:01:00 Benzinga
STAMFORD, Conn., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (NASDAQ:CARA), a biopharmaceutical company focused on developing and …
   Cara President & CEO to Lead National Social Enterprise Organization  2021/02/16 15:00:00 PR Newswire
CHICAGO, Feb. 16, 2021 /PRNewswire/ -- Cara and its Board of Directors announced today that Maria Kim, President & CEO, will be stepping down from the Chicago-based organization after more than 15 years of service. Ms. Kim has accepted the role of President of REDF, a national venture…
   Cara and Poppy Delevingne list colorful LA sister home for $3.75M  2021/02/15 21:09:40 New York Post
Cara and Poppy Delevingne are letting go of their vibrant Los Angeles "dream sister house," and putting it on the market.
   The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed  2021/02/12 13:10:51 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 12) 4D Molecular Therapeutics Inc (NASDAQ: FDMT ) Adagene Inc (NASDAQ: ADAG ) (went public Tuesday) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) AnaptysBio Inc (NASDAQ: ANAB ) (received a double upgrade from JPMorgan) AngioDynamics, Inc. (NASDAQ: ANGO ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) argenx SE – ADR (NASDAQ: ARGX ) Atea Pharmaceuticals Inc (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) Ayala Pharmaceuticals Inc (NASDAQ: AYLA ) Bausch Health Companies Inc (NYSE: BHC ) Bolt Biotherapeutics Inc (NASDAQ: BOLT ) C4 Therapeutics Inc (NASDAQ: CCCC ) Cara Therapeutics Inc (NASDAQ: CARA ) Celcuity Inc (NASDAQ: CELC ) Checkpoint Therapeutics Inc (NASDAQ: CKPT ) Collplant Biotechnologies Ltd – ADR (NASDAQ: CLGN ) DermTech Inc (NASDAQ: DMTK ) ( announced award of contract for coverage of its skin cancer gene expression test) ESSA Pharma Inc (NASDAQ: EPIX ) (reacted to first-quarter results) Evogene Ltd (NASDAQ: EVGN ) FibroGen Inc (NASDAQ: FGEN ) G1 Therapeutics Inc (NASDAQ: GTHX ) Genetron Holdings Ltd – ADR (NASDAQ: GTH ) GenMark Diagnostics, Inc (NASDAQ: GNMK ) (moved on M&A speculation) Guardant Health Inc (NASDAQ: GH ) Guardion Health Sciences Inc (NASDAQ: GHSI ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunome Inc (NASDAQ: IMNM ) Infinity Pharmaceuticals Inc.
   Cara Therapeutics, Inc. (NASDAQ:CARA) CEO Derek T. Chalmers Sells 6,078 Shares  2021/01/02 10:32:41 Watchlist News
Cara Therapeutics, Inc. (NASDAQ:CARA) CEO Derek T. Chalmers sold 6,078 shares of the business’s stock in a transaction that occurred on Wednesday, December 30th. The stock was sold at an average price of $15.30, for a total value of $92,993.40. Following the sale, the chief executive officer now owns 936,593 shares of the company’s stock, […]
   Stamford-based Cara Therapeutics seeks FDA approval for drug for kidney-disease patients  2020/12/28 19:00:00 CT Insider
If the FDA approves Cara Therapeutics’ application, its Korsuva injection would be the Stamford-based company’s first treatment to go on the market.
   Derek T. Chalmers Sells 7,500 Shares of Cara Therapeutics, Inc. (NASDAQ:CARA) Stock  2020/12/14 10:40:42 Watchlist News
Cara Therapeutics, Inc. (NASDAQ:CARA) CEO Derek T. Chalmers sold 7,500 shares of the business’s stock in a transaction on Thursday, December 10th. The stock was sold at an average price of $15.29, for a total transaction of $114,675.00. Following the transaction, the chief executive officer now owns 933,921 shares in the company, valued at $14,279,652.09. […]
   Asia Pacific Medical Marijuana Market Assessments Report 2020 | Cannabis Sativa, Cara Therapeutics, CannaGrow Holdings, Growbox Sciences, United Cannabis, GreenGro Technologies, Lxaria Crop  2020/11/23 17:02:23 OpenPR
Medical marijuana is a type of drug that is used to treat a number of medical conditions such as chronic pain, Alzheimer’s, depression, nausea, cancer, and epilepsy. Since marijuana is a highly addictive drug, governments of several countries have enforced
   Stamford-based Cara Therapeutics ranks in Top 10 of Deloitte Fast 500  2020/11/23 13:00:00 CT Insider
Stamford-based biotech firm Cara Therapeutics is one of the fastest-growing companies in the country, according to a new ranking from Deloitte.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 キャラ・セラピュ―ティックス CARA Cara Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)